MedTrace Logo

An Early Warning Model for Assessing the Onset, Progression and Sequelae of COVID-19

NCT05761652 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 378

Last updated 2023-03-09

No results posted yet for this study

Summary

Based on the characteristics of symptoms, differences in physical and chemical examinations and tests, and characteristics of traditional Chinese medicine (TCM) disease differentiation and syndrome differentiation, the evaluation indicators for the clinical early warning model were screened, and the "three-level early warning mechanism for COVID-19 patients at high risks, with progression to severe cases and sequelae was constructed.

Conditions

Interventions

OTHER

Observe and record

The general information, environmental indicators, and auxiliary examination indicators of the subjects were observed and recorded, as well as the TCM physical assessment was performed.

Sponsors & Collaborators

  • Beijing YouAn Hospital

    collaborator OTHER

  • Kossamak Hospital

    collaborator UNKNOWN

  • Kamuzu University of Health Sciences

    collaborator OTHER

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2024-02-01
Completion
2024-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05761652 on ClinicalTrials.gov